Chancroid 

  • Author: Pamela Arsove, MD, FACEP; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Dec 1, 2010
 

Background

Chancroid is a sexually transmitted disease (STD) characterized by painful necrotizing genital ulcers that may be accompanied by inguinal lymphadenopathy. It was once endemic to many areas of the world, but social awareness of the disease and subsequent changes in characteristics of commercial sexual networks, along with improved diagnosis and treatment options, have eliminated chancroid as an endemic disease in industrialized countries. It remains prevalent in certain underdeveloped regions such as Asia, Africa, and the Caribbean. Chancroid is a subclass of sexually transmitted genital ulcerative diseases that are of worldwide concern due to their role as cofactors in the transmission of HIV.[1, 2]

This photograph shows an early chancroid on the peThis photograph shows an early chancroid on the penis, along with accompanying regional lymphadenopathy. Courtesy of the CDC/Dr. Pirozzi.
Next

Pathophysiology

Chancroid is caused by Haemophilus ducreyi a, a small, gram-negative, facultative anaerobic bacillus. It produces a cytocidal distending toxin that appears to be responsible for its toxic effects. Chancroid is transmitted sexually by direct contact with purulent lesions, and by autoinoculation to nonsexual sites such as the eye and skin. The organism has an incubation period from 1 day to 2 weeks, with a median time of 5-7 days. The disease typically begins as a small inflammatory papule at the site of inoculation; within days, the papule erodes to form an extremely painful deep ulceration. Without treatment, the lesions may last weeks to months, and complications such as suppurative lymphadenopathy are more likely.[3, 4, 5]

Previous
Next

Epidemiology

Frequency

United States

Information regarding STD prevalence in the United States is obtained from the Centers for Disease Control (CDC), which collects data from state health departments. It has published information regarding prevalence of chancroid dating back to 1941, when 3,384 cases were reported. More recently, the incidence of chancroid has declined steadily from 1987 when over 5000 cases were reported to the CDC. In 2008, 25 cases were reported from 9 different states.

In the past, the disease was considered endemic in several large US cities but is currently seen in sporadic cases associated with low socioeconomic status, poor hygiene, prostitution among sex workers, and drug abuse. In 2008, only 25 cases were reported to the CDC, with 8 of these cases from Texas. The true incidence is difficult to determine, and underestimated, because of unavailable diagnostic resources in underdeveloped countries where the disease is most prevalent, and because of the difficulties in culturing H ducreyi even when laboratory resources are available.[6]

International

The true incidence of chancroid worldwide is unavailable because no specific monitoring for this disease exists. Data from the World Health Organization (WHO) in 1995 suggested that 7 million cases of chancroid existed worldwide. Globally, it has been surpassed by HSV-2 as the most common genital ulcerative disease. Chancroid is prevalent in Africa, the Caribbean basin, and Southwest Asia. It is thought to be the most common cause of genital ulceration in Kenya, Gambia, and Zimbabwe.[7, 8, 9]

Mortality/Morbidity

  • Chancroid is not a lethal disease. It is characterized by one or more painful genital ulcers that are associated with unilateral painful inguinal lymphadenopathy in 50% of the cases. Left untreated, suppurative bubo formation occurs in approximately 25% of cases, which can progress to spontaneous rupture with formation of a deep nonhealing inguinal ulcer. Chancroid is easily curable with appropriate antibiotic therapy, although patients with HIV require longer courses of therapy. The true impact of the disease lies in the well-known association of genital ulcer disease with increased transmission rates of HIV and other STDs. Previous infection does not confer immunity against the disease, and reinfection is possible.[10]
  • Superinfection of lesions, known as phagedenic chancroid, may lead to widespread disfiguring necrosis and may require surgical excision.

Race

Although no proven racial predilection exists, chancroid is most commonly observed in nonwhite people.

Sex

Chancroid is most commonly observed in nonwhite men who are uncircumcised. Women represent only 10% of known cases because they are more likely to be asymptomatic carriers.

Chancroid is more commonly identified in individuals of lower socioeconomic status, prostitutes and travellers from endemic areas. According to Benson and Hergenroeder,[11] there have been no reported cases of chancroid among homosexual males, bisexuals or lesbian females.

Age

Although it can affect people of any age, chancroid predominantly affects younger sexually active people. Females aged 15-19 years have the highest prevalence among women in the United States, followed by those aged 20-24 years. In males, the highest prevalence is in those aged 20-24 years.

Previous
 
 
Contributor Information and Disclosures
Author

Pamela Arsove, MD, FACEP  Associate Residency Director, Department of Emergency Medicine, Hofstra Northshore Long Island Jewish School of Medicine; Attending Physician, Department of Emergency Medicine, Long Island Jewish Medical Center; Assistant Professor, Department of Emergency Medicine, Albert Einstein College of Medicine

Pamela Arsove, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Barbara Edwards, MD  Associate Physician, Division of Infectious Diseases, Department of Medicine, Long Island Jewish Medical Center; Assistant Professor, Department of Medicine, Albert Einstein College of Medicine of Yeshiva University

Barbara Edwards, MD is a member of the following medical societies: American College of Physicians, Infectious Diseases Society of America, and Society for Healthcare Epidemiology of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Larry I Lutwick, MD  Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus

Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Charles V Sanders, MD  Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: Alliance for the Prudent Use of Antibiotics, Alpha Omega Alpha, American Association for the Advancement of Science, American Association of University Professors, American Clinical and Climatological Association, American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Foundation for AIDS Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association for Professionals in Infection Control and Epidemiology, Association of American Medical Colleges, Association of American Physicians, Association of Professors of Medicine, Infectious Disease Society for Obstetrics and Gynecology, Infectious Diseases Society of America, Louisiana State Medical Society, Orleans Parish Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southeastern Clinical Club, Southern Medical Association, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology

Disclosure: Baxter International and Johnson & Johnson Royalty Other

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. Janowicz DM, Ofner S, Katz BP, Spinola SM. Experimental Infection of Human Volunteers with Haemophilus ducreyi: Fifteen Years of Clinical Data and Experience. J Infect Dis. Jun 1 2009;199(11):1671-9. [Medline].

  2. Mohammed TT, Olumide YM. Chancroid and human immunodeficiency virus infection--a review. Int J Dermatol. Jan 2008;47(1):1-8. [Medline].

  3. Bauer ME, Townsend CA, Doster RS, Fortney KR, Zwickl BW, Katz BP, et al. A fibrinogen-binding lipoprotein contributes to the virulence of Haemophilus ducreyi in humans. J Infect Dis. Mar 1 2009;199(5):684-92. [Medline].

  4. Leduc I, Banks KE, Fortney KR, Patterson KB, Billings SD, Katz BP, et al. Evaluation of the repertoire of the TonB-dependent receptors of Haemophilus ducreyi for their role in virulence in humans. J Infect Dis. Apr 15 2008;197(8):1103-9. [Medline].

  5. Banks KE, Fortney KR, Baker B, Billings SD, Katz BP, Munson RS Jr, et al. The enterobacterial common antigen-like gene cluster of Haemophilus ducreyi contributes to virulence in humans. J Infect Dis. Jun 1 2008;197(11):1531-6. [Medline].

  6. CDC. 2008 Sexually Transmitted Diseases Surveillance. Center for Disease Control and Prevention. Available at http://www.cdc.gov/std/stats08/other.htm. Accessed 11/11/10.

  7. World Health Organization. An overview of selected curable sexually transmitted diseases. World Health Organization. Available at http://www.who.int/asd/figures/globalreport.html#chancroid. Accessed 10/28/10.

  8. Corbell, Catherine BPharm, MSc*; Stergachis, Andy PHD†‡; Ndowa, Francis MBChB§; Ndase, Patrick MBChB, et al. Genital Ulcer Disease Treatment Policies and Access to Acyclovir in Eight Sub-Saharan African Countries. Sexually Transmitted Diseases. August 2010;37:488-493. [Full Text].

  9. Wang CC, Celum CL. Global risk of sexually transmitted diseases. Med Clin North Am. Jul 1999;83(4):975-95, vi. [Medline].

  10. Hand WL. Haemophilus species including chancroid. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Pa:. Churchill Livingstone;2000:2380-2381.

  11. Benson PA, Hergenroeder AC. Bacterial sexually transmitted infections in gay, lesbian, and bisexual adolescents: medical and public health perspectives. Semin Pediatr Infect Dis. Jul 2005;16(3):181-91. [Medline].

  12. H A Weiss, S L Thomas, S K Munabi, R J Hayes. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect. 2006;82:101-110. [Full Text].

  13. Mohammed TT, Olumide YM. Chancroid and human immunodeficiency virus infection--a review. Int J Dermatol. Jan 2008;47(1):1-8. [Medline]. [Full Text].

  14. Alfa M. The laboratory diagnosis of Haemophilus ducreyi. Can J Infect Dis Med Microbiol. Jan 2005;16(1):31-4. [Medline].

  15. T R Suntoke, A Hardick, A A R Tobian, et al. Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect. April/2009;85:97-101. [Medline]. [Full Text].

  16. Rosen T, Vandergriff T, Harting M. Antibiotic use in sexually transmissible diseases. Dermatol Clin. Jan 2009;27(1):49-61. [Medline].

  17. Czelusta A, Yen-Moore A, Van der Straten M. An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol. Sep 2000;43(3):409-32; quiz 433-6. [Medline].

  18. Mohammed, T. T. and Olumide, Y. M. Chancroid and human immunodeficiency virus infection - a review. International Journal of Dermatology [serial online]. 2008;47:1-8. Available from: doi: 10.1111/j.1365-4632.2007.03435.x. Accessed 11/12/2010. Available at http://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2007.03435.x/full.

  19. Zuckerman JM. Macrolides and ketolides: azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am. 2004;18:621-649. [Medline].

Previous
Next
 
This photograph shows an early chancroid on the penis, along with accompanying regional lymphadenopathy. Courtesy of the CDC/Dr. Pirozzi.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.